Prevention of infections in granulocytopenic and immunocompromised cancer patients.
D000380:Agranulocytosis / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000517:prevention & control*; D006801:Humans; D007108:Immune Tolerance; D017053:Infection Control; D009369:Neoplasms / Q000150:complications*
D000900:Anti-Bacterial Agents